Centrient Pharmaceuticals Netherlands
Centrient Pharmaceuticals is a leading global manufacturer of sustainable antibiotics, next-generation statins, and anti-fungals. Headquartered in the Netherlands, the company operates an extensive global network of production sites and sales offices, serving the pharmaceutical industry with high-quality Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDF). In Spain, Centrient maintains a major manufacturing and operational hub in Santa Perpètua de Mogoda, near Barcelona. The site is critical for their global supply chain, offering diverse opportunities in production, quality assurance, engineering, and regulatory affairs. As a global entity, they provide an international environment suitable for professionals looking to work in a highly regulated and essential healthcare sector.
Company History
Centrient was formerly known as DSM Sinochem Pharmaceuticals, a joint venture established in 2011. In 2018, it was acquired by Bain Capital and rebranded as Centrient Pharmaceuticals in 2019.
For International Professionals
- Operates a major manufacturing facility in Santa Perpètua de Mogoda, located within the Barcelona metropolitan area.
- Global leader in the production of sustainable enzymatic antibiotics and statins.
- Offers a wide range of technical roles in engineering, quality control, and pharmaceutical production.
- The company maintains a strong focus on sustainability and environmentally friendly manufacturing processes.